NCT07739004

Brief Summary

This multicenter prospective observational cohort study evaluates how well the initial triage category assigned by the Turkish Ministry of Health three-level color-coded triage system (Red-Yellow-Green) predicts serious clinical outcomes in children aged 0-18 years who present with fever to pediatric emergency departments. The study additionally assesses whether physiological parameters recorded at triage (heart rate, respiratory rate, oxygen saturation, capillary refill time, AVPU level of consciousness, and general appearance) provide independent and incremental prognostic value beyond the assigned triage category. Ten centers across Turkey will enroll consecutive eligible febrile children over a 3-month period. Routine clinical care and triage decisions are not altered by the study. The primary outcome is a composite serious clinical outcome. The study is reported in accordance with the STROBE and TRIPOD statements.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
4mo left

Started Aug 2026

Shorter than P25 for all trials

Geographic Reach
1 country

10 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 27, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 31, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

July 31, 2026

Status Verified

July 1, 2026

Enrollment Period

3 months

First QC Date

July 27, 2026

Last Update Submit

July 27, 2026

Conditions

Keywords

pediatric triagefebrile childrenclinical prediction modelemergency departmentphysiological parametersundertriage

Outcome Measures

Primary Outcomes (1)

  • Composite serious clinical outcome

    Presence of at least one of: intensive care unit admission; invasive or non-invasive mechanical ventilation; vasopressor/inotropic therapy; culture- or sterile-body-fluid-confirmed invasive bacterial infection; 30-day mortality.

    30 Dys

Secondary Outcomes (7)

  • Hospital admission with intravenous antibiotics

    Up to 30 days

  • Sepsis protocol activation

    Index ED visit (day 1)

  • Intravenous fluid bolus of at least 20 mL/kg

    Index ED visit (day 1)

  • Unplanned re-attendance with admission

    72 hours

  • All-cause hospital ward admission

    Index ED visit (day 1)

  • +2 more secondary outcomes

Study Arms (1)

Febrile children in the pediatric emergency department

Children aged 0-18 years presenting with fever (\>=38.0 C at triage or history of fever within the preceding 24 hours) to a participating pediatric emergency department during the 3-month study period. All undergo routine triage with the Ministry of Health three-level color-coded system; triage decisions and clinical care are not altered by the study.

Diagnostic Test: Ministry of Health three-level color-coded triage

Interventions

At presentation, each child is assigned a triage category (Red, Yellow, or Green) by the triage nurse using the Turkish Ministry of Health three-level color-coded system, and physiological parameters (heart rate, respiratory rate, oxygen saturation, capillary refill time, AVPU level of consciousness, and general appearance) are recorded on a standardized triage form. This reflects routine care and is not modified for the study.

Febrile children in the pediatric emergency department

Eligibility Criteria

Age0 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Consecutive children aged 0-18 years presenting with fever to the participating pediatric emergency departments during the study period.

You may qualify if:

  • Age 0-18 years
  • Presentation to the pediatric emergency department
  • Fever \>=38.0 C at triage OR history of fever within the preceding 24 hours

You may not qualify if:

  • Presentation due to trauma
  • Elective visits
  • Missing triage data
  • Re-attendance within 72 hours for the same episode (only the first visit is included)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Erciyes University Faculty of Medicine

Kayseri, Talas, 38039, Turkey (Türkiye)

Location

Adana City Training and Research Hospital

Adana, Turkey (Türkiye)

Location

Cukurova University Faculty of Medicine

Adana, Turkey (Türkiye)

Location

Akdeniz University Faculty of Medicine

Antalya, Turkey (Türkiye)

Location

Osmangazi University Faculty of Medicine

Eskişehir, Turkey (Türkiye)

Location

Kartal Dr. Lutfi Kirdar City Hospital

Istanbul, Turkey (Türkiye)

Location

Dokuz Eylul University Faculty of Medicine

Izmir, Turkey (Türkiye)

Location

Kayseri City Hospital

Kayseri, Turkey (Türkiye)

Location

Celal Bayar University Faculty of Medicine

Manisa, Turkey (Türkiye)

Location

Tokat University Faculty of Medicine

Tokat Province, Turkey (Türkiye)

Location

Related Publications (4)

  • Fleming S, Thompson M, Stevens R, Heneghan C, Pluddemann A, Maconochie I, Tarassenko L, Mant D. Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. Lancet. 2011 Mar 19;377(9770):1011-8. doi: 10.1016/S0140-6736(10)62226-X.

    PMID: 21411136BACKGROUND
  • Riley RD, Ensor J, Snell KIE, Harrell FE Jr, Martin GP, Reitsma JB, Moons KGM, Collins G, van Smeden M. Calculating the sample size required for developing a clinical prediction model. BMJ. 2020 Mar 18;368:m441. doi: 10.1136/bmj.m441. No abstract available.

    PMID: 32188600BACKGROUND
  • von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007 Oct 20;370(9596):1453-7. doi: 10.1016/S0140-6736(07)61602-X.

    PMID: 18064739BACKGROUND
  • Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med. 2015 Jan 6;162(1):55-63. doi: 10.7326/M14-0697.

    PMID: 25560714BACKGROUND

MeSH Terms

Conditions

FeverSepsisEmergencies

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and SymptomsInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesDisease Attributes

Study Officials

  • Yilmaz Secilmis

    TC Erciyes University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 27, 2026

First Posted

July 31, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

July 31, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared publicly. De-identified data may be made available from the coordinating center on reasonable request, subject to approval by the coordinating ethics committee and a data-sharing agreement, in accordance with institutional and national data-protection regulations.

Locations